Acadian Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Sell |
139,121
-17,093
| -11% | -$90.3K | ﹤0.01% | 1055 |
|
|
2025
Q1 | $1.21M | Hold |
156,214
| – | – | ﹤0.01% | 883 |
|
|
2024
Q4 | $2.07M | Hold |
156,214
| – | – | 0.01% | 756 |
|
|
2024
Q3 | $1.56M | Buy |
156,214
+21,625
| +16% | +$216K | ﹤0.01% | 814 |
|
|
2024
Q2 | $3M | Buy |
134,589
+34,434
| +34% | +$767K | 0.01% | 649 |
|
|
2024
Q1 | $5.88M | Buy |
100,155
+1,398
| +1% | +$82.1K | 0.02% | 433 |
|
|
2023
Q4 | $2.19M | Buy |
98,757
+34,153
| +53% | +$756K | 0.01% | 650 |
|
|
2023
Q3 | $1.39M | Buy |
+64,604
| New | +$1.39M | 0.01% | 781 |
|
|
2022
Q1 | – | Sell |
-56
| Closed | -$19K | – | 1687 |
|
|
2021
Q4 | $19K | Buy |
+56
| New | +$19K | ﹤0.01% | 1614 |
|
|
2021
Q3 | – | Sell |
-844
| Closed | -$562K | – | 1803 |
|
|
2021
Q2 | $562K | Buy |
844
+180
| +27% | +$120K | ﹤0.01% | 1111 |
|
|
2021
Q1 | $576K | Buy |
664
+640
| +2,667% | +$555K | ﹤0.01% | 1141 |
|
|
2020
Q4 | $22K | Buy |
+24
| New | +$22K | ﹤0.01% | 2134 |
|
|
2020
Q2 | – | Sell |
-27
| Closed | -$23K | – | 2261 |
|
|
2020
Q1 | $23K | Sell |
27
-115
| -81% | -$98K | ﹤0.01% | 1634 |
|
|
2019
Q4 | $152K | Buy |
+142
| New | +$152K | ﹤0.01% | 1353 |
|
|
2017
Q3 | – | Sell |
-3,180
| Closed | -$2.57M | – | 1436 |
|
|
2017
Q2 | $2.57M | Sell |
3,180
-2,760
| -46% | -$2.23M | 0.01% | 521 |
|
|
2017
Q1 | $3.66M | Buy |
5,940
+5,558
| +1,455% | +$3.43M | 0.02% | 478 |
|
|
2016
Q4 | $204K | Buy |
+382
| New | +$204K | ﹤0.01% | 998 |
|
|
2016
Q3 | – | Sell |
-259
| Closed | -$106K | – | 1465 |
|
|
2016
Q2 | $106K | Buy |
+259
| New | +$106K | ﹤0.01% | 1021 |
|
|
2016
Q1 | – | Sell |
-139
| Closed | -$106K | – | 1402 |
|
|
2015
Q4 | $106K | Buy |
+139
| New | +$106K | ﹤0.01% | 1062 |
|